title: Comparison of starting antiemetic treatment 24 hours before or concurrently with cytotoxic chemotherapy.
authors.affiliation: CRC Medical Oncology Unit, Southampton General Hospital.
authors.forename: C J
authors.initials: CJ
authors.lastname: Williams
authors.forename: C
authors.initials: C
authors.lastname: Davies
authors.forename: M
authors.initials: M
authors.lastname: Raval
authors.forename: J
authors.initials: J
authors.lastname: Middleton
authors.forename: J
authors.initials: J
authors.lastname: Luken
authors.forename: B
authors.initials: B
authors.lastname: Stone
mesh_terms: D000284:Administration, Oral; D000932:Antiemetics / Q000008:administration & dosage* / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D004294:Domperidone / Q000008:administration & dosage / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D009325:Nausea / Q000139:chemically induced / Q000517:prevention & control; D011897:Random Allocation; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
chemical_list: D000932:Antiemetics; D004294:Domperidone; D003907:Dexamethasone